Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

Acta Psychiatrica Scandinavica

Volumn 125, Issue 4, 2012, Pages 303-308

  Magalhaes P V ^a,b   Kapczinski, F ^a   Nierenberg, A A ^c   Deckersbach, T ^c   Weisinger, D ^d   Dodd, S ^b,d   Berk, M ^b,d,e,f  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b DEAKIN UNIVERSITY   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Age at onset; Bipolar disorder; Cardiovascular; Comorbidity; Course; Depression; Diabetes; Mania; Medical burden; Outcome; Smoking; Staging; Treatment

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHRONIC DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MOOD DISORDER; OPEN STUDY; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; SMOKING; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; COST OF ILLNESS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NERVOUS SYSTEM DISEASES; PREVALENCE; THYROID DISEASES;

EID: 84858118235     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01794.x     Document Type: Article

References (40)

1. Fenn HH, Bauer MS, Altshuler L et al. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord 2005;86:47-60.
2. Beyer J, Kuchibhatla M, Gersing K, Krishnan KR. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacol 2005;30:401-404.
3. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006;68:684-691.
4. Soreca I, Fagiolini A, Frank E, Houck PR, Thompson WK, Kupfer DJ. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008;42:956-961.
5. Altamura AC, Serati M, Albano A, Paoli RA, Glick ID, Dell'osso B. An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatry Clin Neurosci 2011;261:489-508.
6. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry 2010;71:1689-1695.
7. Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry 2006;67:25-30.
8. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv 2009;60:147-156.
9. Soreca I, Frank E, Kupfer DJ. The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? Depress Anxiety 2009;26:73-82.
10. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005;293:2528-2530.
11. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008;32:675-692.
12. Kapczinski F, Dal-Pizzol F, Teixeira AL et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 2010;15:784-786.
13. Kapczinski F, Dal-Pizzol F, Teixeira AL et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res England: A 2010 Elsevier Ltd; 2011;45:156-161.
14. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2010;35:804-817.
15. Gomes F, Kauer-Sant'Anna M, Magalhaes P et al. Obesity is associated with previous suicide attempts in bipolar disorder. Acta Neuropsychiatr 2010;22:63-67.
16. Sachs GS, Thase ME, Otto MW et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003;53:1028-1042.
17. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-224.
18. Perlis RH, Dennehy EB, Miklowitz DJ et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord 2009;11:391-400.
19. Perlis RH, Ostacher MJ, Miklowitz DJ et al. Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry 2010;71:194-200.
20. Goldberg JF, Brooks JO III, Kurita K et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry United States: 2009 Physicians Postgraduate Press, Inc.; 2009;70:155-162.
21. Sheehan DV, Janavs J, Baker R et al. MINI - Mini International Neuropsychiatric Interview - English Version 5.0.0 - DSM-IV. J Clin Psychiatry 1998;59:34-57.
22. Sachs GS, Guille C, Mcmurrich SL. A clinical monitoring form for mood disorders. Bipolar Disord 2002;4:323-327.
23. Berk M, Brnabic A, Dodd S et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention Bipolar Disord 2011;13:87-98.
24. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
25. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004;66:411-421.
26. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3:21.
27. Pasco JA, Kotowicz MA, Henry MJ et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006;296:1353-1355.
28. Pasco JA, Nicholson GC, Williams LJ et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010;197:372-377.
29. Pasco JA, Jacka FN, Williams LJ et al. Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 2010;79:323-325.
30. Mcgorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 2007;164:859-860.
31. Berk M, Singh A, Kapczinski F. When illness does not get better: do we need a palliative psychiatry? Acta Neuropsychiatr 2008;20:165-166.
32. Macneil CA, Hasty MK, Berk M et al. Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Interv Psychiatry 2011;5:100-107.
33. Berk M, Hallam K, Malhi GS et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health 2010;19:113-126.
34. Kilbourne AM, Post EP, Nossek A, Drill L, Cooley S, Bauer MS. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a Randomized controlled trial. Psychiatr Serv 2008;59:760-768.
35. Sylvia LG, Nierenberg AA, Stange JP, Peckham AD, Deckersbach T. Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder. J Psychiatr Pract 2011;17:224-232.
36. Jacka FN, Pasco JA, Mykletun A et al. Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry 2010;167:305-311.
37. Jacka FN, Pasco JA, Williams LJ et al. Lower levels of physical activity in childhood associated with adult depression. J Sci Med Sport 2011;14:222-226.
38. Jacka FN, Pasco JA, Mykletun A et al. Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord 2011;129:332-337.
39. Pasco JA, Williams LJ, Jacka FN et al. Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int Psychogeriatr 2011;23:292-298.
40. Garcia-Portilla MP, Saiz PA, Benabarre A et al. Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatr Scand 2010;121:437-445.